Proglumetacin

DB13527InvestigationalSmall molecule

Proglumetacin is a non-steroidal anti-inflammatory medication used to manage pain associated with various inflammatory conditions including rheumatoid arthritis and osteoarthritis.

Chemical structure of Proglumetacin
Formula / weight
C46H58ClN5O8 · 844.45 g/mol (avg)

Resolves to

Compound
UNIIFV919079LUCAS57132-53-3ChEMBLCHEMBL2105825ChEBI76263KEGGD08427
Clinical / RWD
RxNorm34769ATCM01AB14
Structure
InChIKeyPTXGHCGBYMQQIG-UHFFFAOYSA-NSMILESCCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)CC2=C(C)N(C(=O)C3=CC=C(Cl)C=C3)C3=C2C=C(OC)C=C3)CC1)NC(=O)C1=CC=CC=C1

What you can answer from here — as of March 06, 2025

1,392Drug interactionsStructured to mechanism, not free text
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
24ContraindicationsEach with its own population and attribute set
Sign in
20Marketed productsAcross 3 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Proglumetacin, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In